Delma Fatima Zohra, Al-Hatmi Abdullah M S, Brüggemann Roger J M, Melchers Willem J G, de Hoog Sybren, Verweij Paul E, Buil Jochem B
Department of Medical Microbiology, Radboud University Medical Centre, 6252 AG Nijmegen, The Netherlands.
Natural & Medical Sciences Research Center, University of Nizwa, Nizwa 616, Oman.
J Fungi (Basel). 2021 Oct 27;7(11):909. doi: 10.3390/jof7110909.
Effective management and treatment of fungal diseases is hampered by poor diagnosis, limited options for antifungal therapy, and the emergence of antifungal drug resistance. An understanding of molecular mechanisms contributing to resistance is essential to optimize the efficacy of currently available antifungals. In this perspective, one of the oldest antifungals, 5-fluorocytosine (5-FC), has been the focus of recent studies applying advanced genomic and transcriptomic techniques to decipher the order of events at the molecular level that lead to resistance. These studies have highlighted the complexity of resistance and provided new insights that are reviewed in the present paper.
真菌疾病的有效管理和治疗受到诊断不佳、抗真菌治疗选择有限以及抗真菌药物耐药性出现的阻碍。了解导致耐药性的分子机制对于优化现有抗真菌药物的疗效至关重要。从这个角度来看,最古老的抗真菌药物之一5-氟胞嘧啶(5-FC),一直是最近研究的焦点,这些研究应用先进的基因组和转录组技术来破译在分子水平上导致耐药性的事件顺序。这些研究突出了耐药性的复杂性,并提供了新的见解,本文将对此进行综述。